Overview

Acute Control of Chronic Hypertension

Status:
Terminated
Trial end date:
2020-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
Phase:
Phase 4
Details
Lead Sponsor:
Albany Medical College
Treatments:
Labetalol